Cargando…
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?
The coronavirus disease 2019 (COVID-19) pandemic is challenging health care systems worldwide. People with myotonic dystrophy type 1 (DM1) represent a high-risk population during infectious disease outbreaks, little is known about the potential impact of COVID-19 on patients with DM1. We studied the...
Autores principales: | Dhont, Sebastiaan, Callens, Rutger, Stevens, Dieter, Bauters, Fre, De Bleecker, Jan L., Derom, Eric, Van Braeckel, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556549/ https://www.ncbi.nlm.nih.gov/pubmed/33052531 http://dx.doi.org/10.1007/s13760-020-01514-z |
Ejemplares similares
-
The pathophysiology of ‘happy’ hypoxemia in COVID-19
por: Dhont, Sebastiaan, et al.
Publicado: (2020) -
Conceptions of the pathophysiology of happy hypoxemia in COVID-19
por: Dhont, Sebastiaan, et al.
Publicado: (2021) -
Myotonic dystrophy
por: Patterson, VH
Publicado: (1990) -
Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017) -
Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates
por: Winblad, Stefan, et al.
Publicado: (2010)